Literature DB >> 28490485

Molecular Characterization of Mycoplasma pneumoniae Infections in Two Rural Populations of Thailand from 2009 to 2012.

Toni Whistler1,2, Pongpun Sawatwong3, Maureen H Diaz4, Alvaro J Benitez4, Bernard J Wolff4, Patranuch Sapchookul3, Somsak Thamthitiwat3, Jonas M Winchell4.   

Abstract

Studies on Mycoplasma pneumoniae in Thailand have focused on urban centers and have not included molecular characterization. In an attempt to provide a more comprehensive understanding of this organism, we conducted a systematic random sampling to identify 3,000 nasopharyngeal swab specimens collected from January 2009 through July 2012 during population-based surveillance for influenza-like illness in two rural provinces. M. pneumoniae was detected by real-time PCR in 175 (5.8%) specimens. Genotyping was performed using the major adhesion protein (P1) and multilocus variable-number tandem-repeat analysis (MLVA). Of the 157 specimens typed, 97 were P1 type 1 and 60 were P1 type 2. Six different MLVA profiles were identified in 149 specimens, with 4/5/7/2 (40%) and 3/5/6/2 (26%) predominating. There was no discrete seasonality to M. pneumoniae infections. Examination of the 23S rRNA sequence for known polymorphisms conferring macrolide resistance revealed that all 141 tested to possess the genotype associated with macrolide susceptibility.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Mycoplasma pneumoniae; community-acquired pneumonia; macrolide resistance; molecular epidemiology

Mesh:

Substances:

Year:  2017        PMID: 28490485      PMCID: PMC5483925          DOI: 10.1128/JCM.00350-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012.

Authors:  Vj Chalker; T Stocki; D Litt; A Bermingham; J Watson; Dm Fleming; Tg Harrison
Journal:  Euro Surveill       Date:  2012-02-09

2.  A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995.

Authors:  K Lind; M W Benzon; J S Jensen; W A Clyde
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

3.  Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand.

Authors:  S J Olsen; S Thamthitiwat; S Chantra; M Chittaganpitch; A M Fry; J M Simmerman; H C Baggett; T C T Peret; D Erdman; R Benson; D Talkington; L Thacker; M L Tondella; J Winchell; B Fields; W L Nicholson; S Maloney; L F Peruski; K Ungchusak; P Sawanpanyalert; S F Dowell
Journal:  Epidemiol Infect       Date:  2010-03-31       Impact factor: 2.451

4.  Development of a multiplex taqMan real-time PCR assay for typing of Mycoplasma pneumoniae based on type-specific indels identified through whole genome sequencing.

Authors:  Bernard J Wolff; Alvaro J Benitez; Heta P Desai; Shatavia S Morrison; Maureen H Diaz; Jonas M Winchell
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 2.803

5.  High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

Authors:  Bin Cao; Chun-Jiang Zhao; Yu-Dong Yin; Fei Zhao; Shu-Fan Song; Lu Bai; Jian-Zhong Zhang; Ying-Mei Liu; Yu-Yu Zhang; Hui Wang; Chen Wang
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

6.  An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.

Authors:  Yun-Fong Ngeow; Subharee Suwanjutha; Teerachai Chantarojanasriri; Fu Wang; Mediadora Saniel; Marissa Alejandria; Po-Ren Hsueh; Lee Ping-Ing; Seung-Chul Park; Jang-Wook Sohn; Ahmad M Aziah; Youning Liu; Wing-Hong Seto; Cecilia C L Ngan; Mangunnegoro Hadiarto; Alsagaff Hood; Yuet-Meng Cheong
Journal:  Int J Infect Dis       Date:  2004-11-25       Impact factor: 3.623

7.  Community-acquired pneumonia requiring hospitalization among U.S. children.

Authors:  Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

8.  Epidemiology and clinical features of Mycoplasma pneumoniae infection in children.

Authors:  Annacarla Defilippi; Michela Silvestri; Angela Tacchella; Raffaella Giacchino; Giovanni Melioli; Eddi Di Marco; Carmela Cirillo; Pasquale Di Pietro; Giovanni A Rossi
Journal:  Respir Med       Date:  2008-08-13       Impact factor: 3.415

9.  Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand.

Authors:  Henry C Baggett; Leonard F Peruski; Sonja J Olsen; Somsak Thamthitiwat; Julia Rhodes; Surang Dejsirilert; Wanna Wongjindanon; Scott F Dowell; Julie E Fischer; Peera Areerat; Denchai Sornkij; Possawat Jorakate; Anek Kaewpan; Prabda Prapasiri; Sathapana Naorat; Leelawadee Sangsuk; Boonchuay Eampokalap; Matthew R Moore; Gloria Carvalho; Bernard Beall; Kumnuan Ungchusak; Susan A Maloney
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

10.  Macrolide-Resistant Mycoplasma pneumoniae, United States.

Authors:  Xiaotian Zheng; Stella Lee; Rangaraj Selvarangan; Xuan Qin; Yi-Wei Tang; Jeffrey Stiles; Tao Hong; Kathleen Todd; Amy E Ratliff; Donna M Crabb; Li Xiao; T Prescott Atkinson; Ken B Waites
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

View more
  7 in total

1.  Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.

Authors:  Elena N Voronina; Maria A Gordukova; Irina E Turina; Olga V Mishukova; Maya A Dymova; Elena V Galeeva; Anatoliy A Korsunskiy; Maxim L Filipenko
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-27       Impact factor: 3.267

2.  Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China.

Authors:  Guanhua Xue; Ming Li; Na Wang; Jing Zhao; Bei Wang; Zhimin Ren; Chao Yan; Chengqing Wu; Yang Liu; He Sun; Min Xu; Hongmei Sun
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

3.  Antimicrobial Susceptibility Profiles and Genetic Characteristics of Mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019.

Authors:  Na Wang; Hong Zhang; Yihua Yin; Xiaogang Xu; Li Xiao; Yang Liu
Journal:  Infect Drug Resist       Date:  2022-08-11       Impact factor: 4.177

4.  Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children.

Authors:  Lifeng Li; Jiayue Ma; Pengbo Guo; Xiaorui Song; Mingchao Li; Zengyuan Yu; Zhidan Yu; Ping Cheng; Huiqing Sun; Wancun Zhang
Journal:  BMC Infect Dis       Date:  2022-09-06       Impact factor: 3.667

5.  High frequency of Mycoplasma pneumoniae among patients with atypical pneumonia in Tehran, Iran.

Authors:  Maryam Arfaatabar; Farzaneh Aminharati; Ghasem Azimi; Abbas Ashtari; Seyed Ali Pourbakhsh; Ensieh Masoorian; Mohammad Reza Pourmand
Journal:  Germs       Date:  2018-09-03

6.  Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia.

Authors:  Angela Rocio Copete; Yudy Alexandra Aguilar; Zulma Vanessa Rueda; Lázaro Agustín Vélez
Journal:  Int J Infect Dis       Date:  2017-11-15       Impact factor: 3.623

7.  Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Authors:  L Xiao; A E Ratliff; D M Crabb; E Mixon; X Qin; R Selvarangan; Y-W Tang; X Zheng; J Dien Bard; T Hong; M Prichard; E Brooks; S Dallas; L B Duffy; K B Fowler; T P Atkinson; K B Waites
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.